The journal of mental health policy and economics
-
J Ment Health Policy Econ · Mar 2009
Psychiatric disorders and the labor market: an analysis by disorder profiles.
A key societal cost of mental illness is its impact on the labor market. In examining the relationship between psychiatric disorders and the labor market, the literature to date either examines psychiatric disorders in broad classes or focuses on the impact of specific conditions. ⋯ Additional research is needed to disentangle the findings presented. For example, it is important to separate the influence of substance use disorders from mood disorder and uncover the pathways by which the different conditions in substance use disorders may influence the job market.
-
J Ment Health Policy Econ · Mar 2009
Randomized Controlled TrialCost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Triply diagnosed patients, who live with HIV and diagnosed mental health and substance abuse disorders, account for at least 13% of all HIV patients. This vulnerable population has substantial gaps in their care, attributable in part to the need for treatment for three illnesses from three types of providers. ⋯ Future trials with interventions with lower baseline levels of integration, longer duration and larger sample sizes may show improvement or slow the decline in quality of life. Future researchers should collect comprehensive cost data, because significant decreases in the cost of hospital care did not necessarily lead to significant decreases in the total cost of health services.
-
J Ment Health Policy Econ · Mar 2009
Randomized Controlled Trial Multicenter StudyA comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
Economic evaluations of healthcare interventions increasingly measure outcomes using quality-adjusted life years (QALYs). The SF-6D and the EQ-5D are alternative ways of generating utility scores for use in QALY estimations, but it is unclear which is most sensitive to change in psychiatric symptom severity. There are also limited data on the sensitivity of these measures to changes in existing clinical indicators in long-term mental health conditions like schizophrenia. ⋯ Further comparisons of the EQ-5D and SF-6D are required.